Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Closure of Buy Back
Jagsonpal Pharmaceuticals completed its share buyback, extinguishing 1,600,000 equity shares. This reduces the company's total equity share capital by 2.38% to 65,539,150 shares.
Jun 02 2026 15:48:01
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Jagsonpal Pharmaceuticals completed the buyback of 16 lakh equity shares at Rs.250 per share, investing Rs.40 crore. The process reduced the total outstanding equity shares to 6.55 crore, with formal extinguishment expected by June 2, 2026.
May 25 2026 14:53:40
Jagsonpal Pharmaceuticals Ltd - 507789 - Post Buyback Public Announcement
Jagsonpal Pharmaceuticals completed its share buyback offer, buying back 10 lakh equity shares at Rs.240 per share. This amounted to a total buyback value of Rs.24 crore, representing 4.14% of the paid-up equity capital.
May 25 2026 13:21:54
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Jagsonpal Pharma's buyback offer period has commenced from May 08, 2026, until May 14, 2026. Shareholders are entitled to tender approximately 7.3% of their holdings.
May 07 2026 15:47:15
Jagsonpal Pharmaceuticals Ltd - 507789 - Submission Of Letter Of Offer For Buy-Back Upto 16,00,000 Equity Shares
Jagsonpal Pharmaceuticals Ltd. has announced a buyback offer to acquire up to 1.6 million equity shares at Rs. 250 per share, totaling Rs. 40 crore. The buyback is via a tender offer route, with the record date set for May 04, 2026. Promoters have stated their intention not to participate, benefiting public shareholders.
May 06 2026 20:13:20
Read More